WizCommerce | $8,000,000 | (Aug 27, 2025)
Nugen | Undisclosed Amount | (Aug 27, 2025)
AiGent | $6,000,000 | (Aug 27, 2025)
Certified by Founder
Lodge
Tome Biosciences
start up
United States
- Watertown, Massachusetts
- 14/12/2023
- Series B
- $213,000,000
Tome Biosciences is the programmable genomic integration (PGI) company. Our technologies allow us to insert any genetic sequence of any size at any location in the genome with site-specific precision. We are writing the final chapter in genomic medicines, delivering cures to patients through cell and integrative gene therapies.
- Industry Biotechnology Research
- Website https://tome.bio/
- LinkedIn https://www.linkedin.com/company/tome-biosciences/about/
Peeko | $3,200,000 | (Aug 27, 2025)
Reframe Systems | $20,000,000 | (Aug 27, 2025)
Palabra.ai | $8,400,000 | (Aug 27, 2025)
Lumaegis | $200,000,000 | (Aug 27, 2025)
Aurasell AI | $30,000,000 | (Aug 27, 2025)
Loman AI | $3,500,000 | (Aug 27, 2025)
LO:TECH | $5,000,000 | (Aug 27, 2025)
Therna Biosciences | $10,000,000 | (Aug 27, 2025)
Hades Mining | $6,398,622 | (Aug 27, 2025)
Pageport | $3,300,000 | (Aug 27, 2025)